ArticleJournal of the National Cancer Institute2025
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling.
Yibai Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it